Macrofood

Macrofood is a life science and nutritional technology company specialized in the development and manufacturing of functional nutrients, probiotics, and bioactive compounds. The company is primarily recognized for its clinically-validated probiotic strain, Lactobacillus rhamnosus SP1, which has been evaluated in triple-blind trials as a live biotherapeutic adjunct for treating chronic and Stage III periodontitis. Macrofood also produces AlphaMeta, a mechanically hydrolyzed polysaccharide-peptide (Alpha-PSP) supplement derived from specialized rice nutrients, designed to support metabolic health and cellular energy. With operations in Chile, Malaysia, and the United States, Macrofood leverages advanced fermentation and dehydration technologies to provide evidence-based solutions for the healthcare, dental, and nutritional sectors.